TNF Pharmaceuticals to execute reverse stock split

* TNF Pharmaceuticals (NASDAQ:TNFA [https://seekingalpha.com/symbol/TNFA]) plans to execute a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares to obtain compliance with Nasdaq's listing standards.
* The reverse stock split will reduce the number of shares of the company’s common stock outstanding as of August 27, 2025, from 178,615,658 shares to 1,786,157 shares. The common stock will begin trading on a split-adjusted basis upon market open on September 2, 2025.
* TNFA --27.3% premarket to $0.0654
* Source: Press Release [https://seekingalpha.com/pr/20214823-tnf-pharmaceuticals-announces-reverse-stock-split-for-nasdaq-listing-compliance]

MORE ON MYMD PHARMACEUTICALS

* Financial information for MyMD Pharmaceuticals [https://seekingalpha.com/symbol/TNFA/income-statement]